MedTrace Logo

Effect Of Robotic Rehabilitation And Vagus Nerve Stimulation In Ischemia Stroke Patients

NCT06381089 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-04-24

No results posted yet for this study

Summary

This study was conducted in patients with ischemic stroke; This study was conducted to examine the effect of robotic rehabilitation and transcutaneous auricular vagal nerve stimulation applied in addition to robotic rehabilitation on the patient's functional level and autonomic nervous system.

40 people over the age of 18 participated in the study. They were randomly divided into two groups: robotic rehabilitation and transcutaneous auricular vagal nerve stimulation applied in addition to robotic rehabilitation. While the robotic rehabilitation group received Lokomat and neurological rehabilitation, the other group received stimulation with the Vagustim device, which is applied non-invasively through the ear, in addition to Lokomat and neurological rehabilitation. Spasticity, autonomic nervous system, walking speed, motor function, quality of life, muscle activity and pain were evaluated in both groups before starting treatment and six weeks after treatment. In the study, significance was evaluated at p\<0.05 level.

Conditions

  • Ischemic Stroke
  • Vagus Nerve Stimulation
  • Robotic Rehabilitation
  • Autonomic Nervous System

Interventions

DEVICE

Robotic Rehabilitation

Lokomat is an exoskeleton type robotic walking device that can support both extremities symmetrically.

DEVICE

Transcutaneous Auricular Vagal Nerve Stimulation

Vagus nerve stimulation is defined as any technique that stimulates the vagus nerve in our body.

Sponsors & Collaborators

  • SEFA HAKTAN HATIK

    lead OTHER

Principal Investigators

  • SEFA HAKTAN HATIK, PhD · Sinop University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-10
Primary Completion
2024-07-10
Completion
2024-08-10

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06381089 on ClinicalTrials.gov